Substance / Medication

Omeprazole sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Evidence-Based Guidelines for the Treatment ofInfection in Korea 2020.
Jung Hye-Kyung, Kang Seung Joo, Lee Yong Chan et al. · Gut Liver · 2021
PMID: 33468712Meta-AnalysisFull text (PMC)
Duodenal ulcer perforation: A systematic literature review and narrative description of surgical techniques used to treat large duodenal defects.
Clinch Darja, Damaskos Dimitrios, Di Marzo Fransesco et al. · J Trauma Acute Care Surg · 2021
PMID: 34254960Meta-Analysis
Laparoscopic Repair for Perforated Peptic Ulcer Disease Has Better Outcomes Than Open Repair.
Quah Gaik S, Eslick Guy D, Cox Michael R · J Gastrointest Surg · 2019
PMID: 30465190Meta-Analysis
Separation and identification of degradation impurities of esomeprazole sodium.
Xiao Chuan, Yuan Yingying, Li Jianwang et al. · Biomed Chromatogr · 2023
PMID: 36733994Other
Physico-chemical solid-state characterization of omeprazole sodium: thermal, spectroscopic and crystallinity studies.
Murakami Fabio S, Lang Karen L, Mendes Cassiana et al. · J Pharm Biomed Anal · 2009
PMID: 19038514Other
Compatibility studies between mannitol and omeprazole sodium isomers.
Agatonovic-Kustrin S, Markovic N, Ginic-Markovic M et al. · J Pharm Biomed Anal · 2008
PMID: 18374534Other
Physical and chemical stability of esomeprazole sodium solutions.
Kupiec Thomas C, Aloumanis Vasileios, Ben Michel et al. · Ann Pharmacother · 2008
PMID: 18614750Other
Physical and thermal characterisation of chiral omeprazole sodium salts.
Markovic Nov, Agotonovic-Kustrin Snezana, Glass Beverley et al. · J Pharm Biomed Anal · 2006
PMID: 16524682Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Omeprazole sodium (substance)
SNOMED CT
441570004
UMLS CUI
C0771315

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.